Australia markets close in 54 minutes

Augmedix, Inc. (AUGX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.7900-0.0600 (-2.11%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 135.98M
Enterprise value 115.61M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.73
Price/book (mrq)5.83
Enterprise value/revenue 2.58
Enterprise value/EBITDA -7.38

Trading information

Stock price history

Beta (5Y monthly) -0.13
52-week change 3-7.31%
S&P500 52-week change 321.08%
52-week high 36.2500
52-week low 32.6100
50-day moving average 33.8897
200-day moving average 34.6950

Share statistics

Avg vol (3-month) 3369.6k
Avg vol (10-day) 3268.26k
Shares outstanding 548.74M
Implied shares outstanding 648.74M
Float 828.91M
% held by insiders 110.16%
% held by institutions 176.67%
Shares short (15 Apr 2024) 41.24M
Short ratio (15 Apr 2024) 42.97
Short % of float (15 Apr 2024) 44.49%
Short % of shares outstanding (15 Apr 2024) 42.54%
Shares short (prior month 15 Mar 2024) 4747.99k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -42.74%
Operating margin (ttm)-34.29%

Management effectiveness

Return on assets (ttm)-23.39%
Return on equity (ttm)-154.69%

Income statement

Revenue (ttm)44.85M
Revenue per share (ttm)1.02
Quarterly revenue growth (yoy)44.90%
Gross profit (ttm)N/A
EBITDA -17.68M
Net income avi to common (ttm)-19.17M
Diluted EPS (ttm)-0.4400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)46.22M
Total cash per share (mrq)0.95
Total debt (mrq)25.85M
Total debt/equity (mrq)110.83%
Current ratio (mrq)2.41
Book value per share (mrq)0.48

Cash flow statement

Operating cash flow (ttm)-15.44M
Levered free cash flow (ttm)-12.56M